CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2,014,785 | 15.70% |
| Memorial Sloan Kettering Cancer Center | 544,196 | $2,312,833 | 7.30% |
| Elmwood Wealth Management, Inc. | 2,364,415 | $10,048,764 | 4.68% |
| PFM Health Sciences, LP | 5,570,869 | $23,676,193 | 0.92% |
| Avidity Partners Management LP | 2,758,600 | $11,724,050 | 0.41% |
| Green Alpha Advisors, LLC | 105,826 | $449,760 | 0.30% |
| Bruce & Co., Inc. | 200,000 | $850,000 | 0.24% |
| SVB FINANCIAL GROUP | 20,714 | $88,035 | 0.17% |
| Rokos Capital Management LLP | 2,748,139 | $11,202,789 | 0.11% |
| Tekla Capital Management LLC | 567,147 | $2,410,375 | 0.09% |